{"name":"Simcere Pharmaceutical Co., Ltd","slug":"simcere-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"SIM0916","genericName":"SIM0916","slug":"sim0916","indication":"Other","status":"phase_3"},{"name":"Edaravone Dexborneol Sequential Therapy","genericName":"Edaravone Dexborneol Sequential Therapy","slug":"edaravone-dexborneol-sequential-therapy","indication":"Acute ischemic stroke","status":"phase_3"},{"name":"Edaravone dexborneol sublingual tablet","genericName":"Edaravone dexborneol sublingual tablet","slug":"edaravone-dexborneol-sublingual-tablet","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SIM0718 Injection","genericName":"SIM0718 Injection","slug":"sim0718-injection","indication":"Chronic hepatitis B","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Gemcitabine-Cisplatin chemotherapy","genericName":"Gemcitabine-Cisplatin chemotherapy","slug":"gemcitabine-cisplatin-chemotherapy","indication":"Non-small cell lung cancer","status":"marketed"}]}],"pipeline":[{"name":"SIM0718 Injection","genericName":"SIM0718 Injection","slug":"sim0718-injection","phase":"phase_3","mechanism":"SIM0718 is a recombinant human serum albumin-interferon alpha fusion protein that enhances antiviral and immunomodulatory responses.","indications":["Chronic hepatitis B","Chronic hepatitis C"],"catalyst":""},{"name":"SIM0916","genericName":"SIM0916","slug":"sim0916","phase":"phase_3","mechanism":"SIM0916 is a small molecule inhibitor that targets a specific molecular pathway involved in disease pathogenesis, though the exact mechanism requires further clarification.","indications":[],"catalyst":""},{"name":"Edaravone Dexborneol Sequential Therapy","genericName":"Edaravone Dexborneol Sequential Therapy","slug":"edaravone-dexborneol-sequential-therapy","phase":"phase_3","mechanism":"Edaravone reduces oxidative stress and neuroinflammation while dexborneol enhances cerebral blood flow and neuroprotection in a sequential combination therapy.","indications":["Acute ischemic stroke"],"catalyst":""},{"name":"Edaravone dexborneol sublingual tablet","genericName":"Edaravone dexborneol sublingual tablet","slug":"edaravone-dexborneol-sublingual-tablet","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gemcitabine-Cisplatin chemotherapy","genericName":"Gemcitabine-Cisplatin chemotherapy","slug":"gemcitabine-cisplatin-chemotherapy","phase":"marketed","mechanism":"Gemcitabine and cisplatin work synergistically to damage cancer cell DNA and prevent its repair, leading to cell death.","indications":["Non-small cell lung cancer","Ovarian cancer","Bladder cancer","Pancreatic cancer","Breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNNzFqVGR6eXVoOEtSZFByNlhCX0FVMVBhRmZTX1lQVnpmUUVCWjVFRHJieG12cUVNVlVWM0hXYTB6V3h1UkVid2lyZGVDNFZmd3pmTkRyeGZLU01XSkV3VDZTelBqOVVOMlBXV0FUTzhub0RUY0RrLUd4ai1JZG1xWVJYU2EtaWZ0MzB4MGJYalpJeFNiUW1lRnM4M2kxb1J1c1JqQ0s3NlRjODI3Sm5DYnJmV3k1U3BfYWFUaXNqYUxyeEgtNzdoMVJIc1M1UUhSVzZkUkpLWXM1bGVHY1FiN1FSRHRmaWVzN2lLNWh5Q3h1MldZZUxfbNIB_gFBVV95cUxPbktzSHk1cThOMFYtY29laWRKaVltOHJmejdFMTFJUnpRVVNpaVQ1THMxQk5wWEt4TlNOQ21wMDBvVTFYbHhhMzQ4dTVtal9XMmM2clVMSDluYVVDNnVnV2MtTFJvOUlVQkVtTHEyRWJHNlQwV1NRUndfRHMzREl2LTBQOG1aTmE3c2ZjYm4yRnJQdEhucGwydWZBVnpYWDRoczVJQVdmbUV1UW5xUURHRExkQ1ZFVFhMUFNqS1VZS19INVlnRlFmVHV4ZnRtNkF0RzBDcXdfZWdWUkljYmZYYmoydFF6UFlBMHdiYnhJazFJQTNERndvcXlkLUV3QQ?oc=5","date":"2026-03-29","type":"pipeline","source":"simplywall.st","summary":"Simcere Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st","headline":"Simcere Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNZTVSaFlSd1NhVHp0YUE4bU1pZWVIdGFIdk1hZmdGUFNsbFNwUXB0Ynh5SkdkNHRUWGY1d0c5OWk2WUd2bUp2TTN0NGhkbUNtY0Q3NkUxaGpPQWNjRHJsdEd2UHd5dURHMzdRU3pGanNDTXl0aGNWYUx2aG51YkRfRmNoS3N0WHVJWlZRTnFSV01rdktSZURxUW9ueU5PcUo2bXBRSGxSMjhrNDU3em9LcHhkcnZtVDhFTDl6ZENyNFRXam1lT2lSN01n?oc=5","date":"2026-03-25","type":"pipeline","source":"TipRanks","summary":"Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary - TipRanks","headline":"Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNUmJKcTk2bUJ0YzQyT0s4VkZPRkdFbGw1bkR4X3ZNaVJ0Y2lJaThxQjBGSFBnbjFlbG5qdFkxQm54UUVUay0zUXFFTV9aZTJlZVZwNHFUX21nN3JMY20zU05SM245SVB6ZUItRGNkWVFFa1pGZTJmbWN5Yl9Nd3F1YWtFM3U5OGxmdWRjSm41UUVybFhfQW9lcVVQaFRQaTVPOXo1R1U3ZFpoM3A1TVZpRV9uTmFUeVppcTRhTEpjRm1TaWp0RWpDbzBhcHFld3NJRXM0Nw?oc=5","date":"2026-03-25","type":"pipeline","source":"TipRanks","summary":"Simcere Pharma Moves to Modernize Articles, Enable Virtual Meetings and Treasury Shares - TipRanks","headline":"Simcere Pharma Moves to Modernize Articles, Enable Virtual Meetings and Treasury Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQb0haNGZnM1RDMGlTMjZHWlBzUlpjWWl6elV5TWtmMDhTa2owaVZRYTZFd1JkUHdQeVpJZ3JONXhHSGVFTWRHVnBMTXcyWVdNYzktVi11MVBEMVNxR0FrZWlfNXJsc2lrR0o1RlRFMU51SllHc2ZmczRVOHVtZmg3SVM4eXl4Y3JHd0UxRlB5SWJGYm5QaFAxNVBhS3ptblh5OGd3dE1sZWV4eENzQXVQUW9QQjBWcS03RGwzdm50cVBqYzBhMUpWRWozemcyM2tYUFJ3bzFsQnZvektFaHZpaC13Y3pHc0l5Q1F3RVBZNXl6Zw?oc=5","date":"2026-03-12","type":"deal","source":"Business Wire","summary":"Almirall Inaugurates Offices in China to Advance Innovation in Medical Dermatology Through Partnerships - Business Wire","headline":"Almirall Inaugurates Offices in China to Advance Innovation in Medical Dermatology Through Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9COGRSMFdsNlktcVBtRU1PdnRPT1RLQ0NidW9pbVRVZjFKNFpXdEFCREV0WEY1cU1tbkJTTmVpZ2dzSVhLVGU5R01RTkdPWGVKTU5JS1lPSHhwalM5bHlTbEpxdmtMMkVpMDQ3WWVHRHJndw?oc=5","date":"2026-02-26","type":"earnings","source":"thebambooworks.com","summary":"BRIEF: Simcere Pharma profit surges in 2025 - thebambooworks.com","headline":"BRIEF: Simcere Pharma profit surges in 2025","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNNXZhOWZBV1o0b2ZBVHNqelB6Y240b1FfRG1mMmVUZjNmS0ZCajc1eU5vUkQxdXREOHlUUm9UN1NkWDBoaDRXTDcteVIxUUtwQmd2N3JtbFFsX3JnSXB1WFI1a2xrU0R1OWhfMUsxYkcyckgwejZyOS1hRlNGYUVBallVRWkyMkgtbGl0b2E3cTJtWklzWldoMGNmRENFek5lRTJWTU85a0VTMkdEVlBhQUd1QjdBeWJ2UGhPNU5ieGFaRy16WXp0Ry1xUjIwcXlsVFNPX094alZ5N0drZEJSc1gxenYxTUxWUDFSRHpYaw?oc=5","date":"2026-02-25","type":"earnings","source":"Minichart","summary":"Simcere Pharmaceutical Issues Profit Alert: FY2025 Revenue and Profit Expected to Surge on Innovative Pharma Growth 12 - Minichart","headline":"Simcere Pharmaceutical Issues Profit Alert: FY2025 Revenue and Profit Expected to Surge on Innovative Pharma Growth 12","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPU1RUQVdCc2lDZDVqcGNIeTRsRWt0ZnlOQ0NZNF95M00xcHVPRW14QnM2clhJOTJtVXM2ZVpIWk5mNEJINmV0NXpOY3dwSWRxSHh4Zy1FMmgtbTF5NjZEYWVXU3F4cS1PV09xZ29qcXI2VzFMbWZEaThwRFJBUjNLNjRTYThOaDMxdDc4ZkIzT25sbHo2SDgtazNJdFdCdzllc3pCMGhNaHlYS2Q1N05jam92TDdzelVJWk5qODAzMHNDODhZTmRQUmxJRlFoQVJQdDNKcVVEY2xRdUhFNjUtT3hJQThpdw?oc=5","date":"2026-01-27","type":"deal","source":"Reuters","summary":"Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate - Reuters","headline":"Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxOdUdTZmtLdXpDMFVyTkw1SXNvZXBPd2NKRVJhNVJqcHV0VmtTbVhhdG9WSGRuaGdSQ25JWEYzamY3bTA4SVBSSUw0SUhMczlIX0lEM0htaGRubUVGZ3FpeDQ0OGF3cHVFcGR2dEdvdlZtN1ZDLTZ0MDg0VWpITWRNc1BObTF4ZElzZmluWTdwOEI1UTJRNERUcDNpbmRic2hUbjNtdG5Yd3lxTF9CZlc3TVdJaE1yV0piMFpxd1lTeHEyM0NURDhKcWZtcGdMWUgwY3ZlYTlPN2dqdE02OWd6dEo0SlEzNHR6eG1mVGVkRVQ5a08tTFpkVjhHc3cxYTBfTjNFdkJJZ0l2dWN5OWZSNVZ4azV0TGxPcUxCaGJB?oc=5","date":"2026-01-27","type":"deal","source":"PR Newswire","summary":"Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease - PR Newswire","headline":"Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNRTd1YWFvZldWdE9VY3dXMEtNTDNUbGd3TndWU05RSGRpb0t1YXNKcXprZkpSdHJpM3dxcGtRb0MzVEdPV09LS29VRzFmTDI4QXEwVjJHUmJzZTI4ZkszcV9JYVZiM082MDVTemoyNnRVbGV3aS1zRk5la2lPWks4c01SVnprZ3h6VTdtUHFfVFdHUFVMY01od3pKWHk4Tlh1Q1RuNzlhYU00UQ?oc=5","date":"2025-12-23","type":"pipeline","source":"Pharmaceutical Technology","summary":"Ipsen outlays $1bn for China-based Simcere’s preclinical ADC - Pharmaceutical Technology","headline":"Ipsen outlays $1bn for China-based Simcere’s preclinical ADC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBGV3lsb3FXNDdYUDF2SjFLRHlwYWswdEdoMG5BRUpOeTFjclBMRjNIWjljUE9XVFUxV0lEeDBxdV9iZy15S0trYWdDTWhuQ2xob1VJLVBPWUdLNHY2RU1nTmtLaElIWkZhcWIyYlJ1bUYzRHlaeDFJZE8wRklLZw?oc=5","date":"2025-10-21","type":"pipeline","source":"China Daily","summary":"Pharma sector transforms for growth - China Daily","headline":"Pharma sector transforms for growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNLTE4Z0JoMnZuUDNwR3NPVEVLS29QdHVHT2dOd2ZSd3RBTnFkRzU1UGN2dDdaRk1Bbm85SVFaWXNHRXJYRDhqUnpNdDM1dXdPTG93OVBRM3BUYUd5Z2J1YkUtMEkxSVlxendIbnlJS09jaUl2RFNNZm9ZOUNZZjBkU3d6ZnJFOGpSWkNOeTdn?oc=5","date":"2025-09-02","type":"pipeline","source":"BioWorld News","summary":"Chinese biopharma financings up in Hong Kong - BioWorld News","headline":"Chinese biopharma financings up in Hong Kong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZmlvc25ja214WmxxSnZScWt3NVFpZXNjQ3lGb05qQjdhYjdiTUc0VmhQekFuT0lZUlYtNjhwXzNDYnNBTnB4aS1PWjNoeXNUM3U3M1R3dlRWOFhSQXVwN3VTY1V0R29nQ3hxMUV4Sk5EV3lBaS1XQnQ1dy1fbUI4SEUzbW5fY00y?oc=5","date":"2024-12-19","type":"pipeline","source":"pharmaphorum","summary":"Innovative sublingual medication for improved stroke care - pharmaphorum","headline":"Innovative sublingual medication for improved stroke care","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":3,"phase_2":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}